throbber
Journal of Chromatography, 536 (1991) 85-93
`Elsevier Science Publishers B.V., Amsterdam
`
`CHROMSYMP. 2028
`
`Large-scale purification of haptenated oligonucleotides using
`high-performance liquid chromatography
`
`RONALD L. MORGAN and JOSEPH E. CELEBUSKI*
`Research and Development, Abbott Laboratories, Abbott Park, JL 60064 (U.S.A.)
`
`ABSTRACT
`
`We report methodology for the succesful separation of unreactcd oligonucleotide from end labeled
`material (fluorescein or biotin) on an milligram scale using high-performance liquid chromatography
`(HPLC). The oligonucleotides (19-24-mers) were synthesized on an automated instrument using cya(cid:173)
`noethylphosphoramidite chemistry. These oligonucleotides possessed a primary amino group at either the
`5' -end or the 3' -end. After trityl-on HPLC purification and detritylation, the amine-terminated oligonucle(cid:173)
`otides were treated with either fluorescein isothiocyanate or biotin-(aminocaproyl) 2-N-hydroxysuccini(cid:173)
`mide active ester to give the haptenated materials. After removal of excess labeling reagent, the labeled
`oligonucleotides were purified by reversed-phase HPLC using a polystyrene-based column, with C 18
`groups on the phenyl part of the polystyrene backbone. The terminally labeled oligonucleotides hybridized
`to their complementary sequences, as observed by size-exclusion chromatography.
`
`INTRODUCTION
`
`In connection with a program designed to commercialize non-radioactive DNA
`probe technology [1], we investigated the covalent labeling of oligonucleotides with
`non-radioactive reporter groups. Several technologies exist to accomplish this ob(cid:173)
`jective. Keller and coworkers [2,3] have introduced haptens onto bulk DNA using
`both nucleophilic attack and photochemistry. Another technique for introduction of
`haptens onto DNA is to synthesize terminally [4] and internally [5] aminated oligonu(cid:173)
`cleotides which can then be specifically labeled with an appropriate hapten. Tous et
`a!. [6] and Smith et al. [7] have obtained ftuoresceinated, terminally labeled oligonu(cid:173)
`cleotides in this fashion. Telser eta!. [8] have prepared oligonucleotides which were
`internally labeled with biotin, fluorescein and pyrene, and studied their thermody(cid:173)
`namic characteristics. Others have chemically labeled oligonucleotides with biotin
`[9-11 ]. While the synthetic chemistry of labeling DNA with small molecules has been
`dealt with in detail, the chromatographic techniques for adequate separation of start(cid:173)
`ing oligonucleotide from product, especially on a milligram scale, are less well in(cid:173)
`vestigated. The aforementioned references use polyacrylamide gel electrophoresis
`(PAGE) or reversed-phase high-performance liquid chromatography (HPLC) col(cid:173)
`umns for their oligonucleotide separations. However, PAGE suffers from a low load(cid:173)
`ing capacity, while reversed-phase HPLC will give coelution of fluorescein isothiocya(cid:173)
`nate (FITC) labeled oligonucleotide with non-labeled oligonucleotide. Biotinylated
`
`0021-9673/91 j$03.50
`
`![:1
`
`1991 Elsevier Science Publishers B.V.
`
`1
`
`MTX1016
`
`

`

`86
`
`R. L. MORGAN, J. E. CELEBUSKI
`
`oligonucleotides show no separation at all on reversed-phase HPLC. In this paper we
`describe the results of a comparative study of several separation conditions for hapte(cid:173)
`nated oligonucleotides.
`
`EXPERIMENTAL
`
`Materials
`Fluorescein isothiocyanate was purchased from Eastman Kodak (Rochester,
`NY, U.S.A.). Biotin-(aminocaproyl)2-N-hydroxysuccinimide ester and Aminomod(cid:173)
`ifier II were obtained from Clontech (Palo Alto, CA, U.S.A.). Triethylamine was
`supplied by Aldrich (Milwaukee, WI, U.S.A.); glacial acetic acid by J. T. Baker
`(Phillipsburg, NJ, U.S.A.); ethanol by Aaper Alcohol and Chemical (Shelbyville, KY,
`U.S.A.); concentrated ammonium hydroxide by Mallinckrodt (Paris, KY, U.S.A.);
`HPLC-grade water and acetonitrile by Fisher (Fair Lawn, NJ, U.S.A.), acrylamide(cid:173)
`N,N' -methylenebisacrylamide (Bis), tetramethylethylenediamine (TEMED), ammo(cid:173)
`nium persulfate, xylene cyanol and Bromophenol Blue by Bio-Rad (Richmond, CA,
`U.S.A.); urea by Boehringer Mannheim (Indianapolis, IN, U.S.A.). NAP-5 Sephadex
`columns were obtained from Pharmacia (Piscataway, NJ, U.S.A.). Amino-controlled
`pore glass was purchased from Glen Research (Herndon, VA, U.S.A.).
`
`Equipment
`A Waters Assoc. (Milford, MA, U.S.A.) HPLC system was used for all HPLC
`separations. This consisted of a 600E system controller, U6K injector, 745B data
`module or NEC Powermate 386/20 and a 484 detector or a 991 photodiode array
`detector. The columns used were Waters J1Bondapak C 18 , 30 x 0.39 em, Hamilton
`(Reno, NV, U.S.A.) PRP-1, 25 x 0.41 em, and EM Science (Cherry Hill, NJ, U.S.A.)
`Polyspher RP-18, 15 x 0.46 em. Oligonucleotides were synthesized on Applied Bio(cid:173)
`systems (Foster City, CA, U.S.A.) 380A or 380B DNA Synthesizers using fJ-cya(cid:173)
`noethylphosphoramidite chemistry with the SYN 11 program, for both the 5'-am(cid:173)
`inated (Clontech) and 3'-aminated (Glen Research) oligonucleotides. Deprotection of
`the oligonucleotides was performed at 5YC for 6 h in concentrated ammonium hy(cid:173)
`droxide. Gel electrophoresis was performed on a Bio-Rad Sequi-Gen apparatus, with
`an E-C apparatus (St. Petersburg, FL, U.S.A.) EC 650 power supply. All HPLC
`separations were performed at ambient temperature. A Beckman (San Ramon, CA,
`U.S.A.) DU-70 spectrophotometer was used for measuring ultraviolet (UV) absorp(cid:173)
`tion spectra. A Savant SpeedVac (Farmingdale, NY, U.S.A.) was used for concentra(cid:173)
`tion of samples and a Jouan (Saint Herblain, France) centrifuge was used for centrifu(cid:173)
`gation.
`
`HPLC purification of trityl-on oligonucleotides
`The aqueous mobile phase (A) for the trityl-on HPLC purification was 0.1 M
`triethylammonium acetate (pH 7.0). The organic mobile phase (B) was acetonitrile.
`The following linear gradient was used: 10 to 40% B in 15 min, hold at 40% B for 10
`min, then linear to 10% Bin 5 min. A Waters J1Bondapak C 18 at 1.5 ml(min was used
`for the trityl-on chromatography. The purified product is collected at approximately
`14 min and concentrated to a residue on a SoeedVac.
`
`2
`
`

`

`HPLC PURIFICATION OF HAPTENATED OLIGONUCLEOTIDES
`
`87
`
`Manual detritylation of oligonucleotides
`The trityl-on purified oligonucleotides were taken up into 1.0 ml of acetic acid(cid:173)
`water (80:20, vfv) and were left to stand at room temperature for 1 h. The solvent was
`removed on a SpeedVac and the residue was taken up into 100 J.ll of 0.3 M sodium
`acetate. Precipitation of the oligonucleotide was initiated by addition of 1.0 ml of
`- 20T ethanol and was effected by immersion of the suspension in a -7SOC (dry
`ice-isopropanol) bath. Centrifugation of the suspension (-lOT, I2 560 g, 15 min)
`gave a pellet which was used for the haptenation reactions.
`
`Synthesis of haptenated oligonucleotides
`Fluoresceinated oligonucleotides. To a solution of 1 J.lmol of detritylated, termi(cid:173)
`nally aminated 24-mer oligonucleotide (determined by UV absorption) in 250 J.ll
`sodium borate buffer (pH 9.0) 8 mg (20 J.lmol) fluorescein isothiocyanate dissolved in
`250 J.ll of dimethylformamide (DMF) was added. The reaction was left to proceed in
`the dark at room temperature for I6 h. The reaction mixture was loaded onto a
`NAP-5 column which had been equilibrated with 10 ml water. The column was eluted
`with 1.0 ml water and the eluate was collected and concentrated on the SpeedVac.
`Biotinylated oligonucleotides. To a solution of 1 J.lmol detritylated, terminally
`aminated 24-mer oligonucleotide in 250 J.ll sodium phosphate buffer (pH 7 .2) II mg
`(20 J.lmol) of biotin-(aminocaproyl)l-N-hydroxysuccinimide ester in 250 t-tl of DMF
`was added. The reaction was left to stand in the dark at room temperature for I7 h.
`The reaction was worked up as in the fluorescein case to give the concentrate, ready
`for HPLC or gel separation.
`
`Polyacrylamide gel electrophoresis of haptenated oligonucleotides
`A 150 ml solution of 12% acrylamide-Bis/8 M urea/89 mM Tris/89 mM sodi(cid:173)
`um borate/2 mM EDT A, pH 8.0 was left to polymerize for 4 h in a 2I x 40 x 0.2 em
`Bio-Rad Sequi-Gen apparatus, after addition of ammonium persulfate and TEMED.
`After pre-electrophoresis of the cell (1 h, 20 W), the oligonecleotides were loaded onto
`the gel. Generally, no more than l t-tmol of oligonucleotide in I 50 t-tl of formamide
`could be applied at once. After 4--5 hat 40 W, the bromophenol blue dye had eluted
`off the gel, signaling the end of the run. At this point, the gel was overlaid on a silica
`gel plate and the DNA bands were visualized by UV shadowing. The product (slowest
`moving major) bands were excised and extracted with I.O M triethylammonium bi(cid:173)
`carbonate overnight. The extracts were concentrated, taken up into 0.5 ml of water
`and desalted on a NAP-5 column. The eluate was checked for DNA concentration by
`UV absorbance.
`
`Reversed-phase HP LC purification of haptenated oligonucleotides (Hamilton P RP-1
`procedure)
`The aqueous mobile phase (A) for the purification of haptenated oligonucleo(cid:173)
`tides was 0.1 M sodium phosphate (pH 8.9). The organic mobile phase (B) was 50%
`aqueous acetonitrile. The following linear gradient was used: 10 to 30% Bin 23 min,
`then 30 to IO% Bin IO min. The flow-rate was I ml/min and the injection volume was
`150 f.ll. The detector was adjusted to 290 nm and 2.0 a.u.f.s.
`
`3
`
`

`

`88
`
`R. L. MORGAN, J. E. CELEBUSKI
`
`Reversed-phase HPLC purification of haptenated oligonucleotides ( Polyspher RP-18,
`EM Science procedure)
`The aqueous mobile phase (A) for the purification of haptenated oligonucleo(cid:173)
`tides was 0.1 M sodium phosphate (pH 8.8). The organic mobile phase (B) was 50%
`aqueous acetonitrile. The following linear gradient was used: 20 to 50% B in 36 min,
`then 50 to 20% Bin 14 min. The flow-rate was 0.6 ml/min and the injection volume
`was 150 J,tL The detector was adjusted to 290 nm and 2.0 a.u.f.s.
`
`Hybridization determination by size-exclusion HPLC
`The ability of haptenated complementary single stranded oligonucleotides to
`hybridize was demonstrated by size-exclusion HPLC using a Bio-Rad Bio-Sil
`SEC-125 as follows: the mobile phase was 0.1 M sodium phosphate (pH 7 .0), the
`flow-rate was 1 ml/min at 280 p.s.i. and the detector was adjusted to 260 nm and 0.5
`a.u.f.s. An aqueous solution of each oligonucleotide, concentration approximately 1
`J,tg per 40 J,tl, was injected individually and each retention time determined for the
`single stranded oligonucleotides. Equivalent amounts of complementary single
`stranded oligonucleotides were mixed at room temperature and injected under the
`previous conditions. Typical retention times for single stranded 24-mers were 7.7-7.9
`min and changed to 7 min when hybridized.
`
`RESULTS AND DISCUSSION
`
`We have found that a 2-mm thick, 21 x 40 em polyacrylamide gel will separate
`labeled from non-labeled material quite well on a 0.5--1.0 J,tmol scale upon electropho(cid:173)
`resis. In all cases observed, labeled material migrates more slowly than non-labeled.
`However, efficiency of separation falls off drastically at higher oligonucleotide load(cid:173)
`ings. Our investigations of separation technology for large-scale work then shifted
`from gel electrophoresis to suitable HPLC columns and conditions. We first exam(cid:173)
`ined the separation afforded by a Waters J,tBondapak c18 HPLC column (30 X 0.39
`em). On an analytical scale (0.1 Jlmol), a C 18 ODS column did not separate biotiny(cid:173)
`lated oligonucleotide from the starting oligonucleotide. We then attempted a sep(cid:173)
`aration of FITC-labeled oligonucleotide from starting, amine-terminated oligonucle(cid:173)
`otide. Due to fluorescein's lipophilicity, one would expect good separation of labeled
`from non-labeled material for fluoresceinated oligonucleotide. In fact, separation was
`seen between fluoresceinated and non-fluoresceinated oligonucleotide (Fig. 1 ). How(cid:173)
`ever, upon further investigation of the fractions by denaturing gel electrophoresis, it
`was determined that peak 1, from Fig. I, was starting oligonucleotide, while peak 2
`was a mixture of starting material and product. Under the non-denaturing chroma(cid:173)
`tographic conditions, it is possible that intercalation of the fluorescein label into a
`neighboring oligonucleotide is occurring. This supposition prompted us to investigate
`the HPLC of oligonucleotides under denaturing conditions.
`One chromatographic support which is well suited for the large-scale separation
`of oligonucleotides under denaturing conditions is polystyrene reversed-phase (PRP)
`material, with divinylbenzene crosslinks. Several studies [12-14] have shown that
`PRP columns possess outstanding loading capacities and will function under ex(cid:173)
`tremes of pH (2-13), as well as at high salt concentration. As shown in Fig. 2, the
`Hamilton PRP-1 column (25 x 0.41 em) will fractionate oligonucleotides. Unfortu-
`
`4
`
`

`

`HPLC PURIFICATION OF HAPTENATED OLIGONUCLEOTIDES
`
`89
`
`1.0
`
`0.8
`
`Absorbance
`A290 run
`
`peak 1 -
`
`-
`
`peak2
`
`0.0
`
`10
`
`20
`
`30
`
`Time
`(minutes)
`
`Fig. 1. Injection of 2.4 pg of a 23-mer, 5'-end labeled with FITC. Peak I, eluting at 16.3 min, is starting
`23-mer. Peak 2, eluting at 17.98 min, is a mixture of starting and fluoresceinated oligonucleotide. Column is
`Waters pBondapak C 18 , flow-rate I ml/min. Gradient table: initial, 5% B, 95% A; 5 min, 20% B, 80% A;
`35 min, 50% B 50% A. Solvent A is 0.1 M triethylammonium acetate, solvent B is acetonitrile.
`
`nately, "ghosting" frequently occurs. Ghosting is a phenomenon in which some in(cid:173)
`jected oligonucleotide is retained on the column during a sample run. The retained
`oligonucleotide is eluted in a subsequent run, when the gradient conditions that elut(cid:173)
`ed the major part of the initial charge are attained. Ghosting was detected when, after
`thoroughly washing the HPLC injector port and syringe, the ghost peak still eluted in
`a blank injection. This even occurs after repeated column washes. Ghosting is seen in
`trityl-on as well as trityl-off HPLC and so is not limited to the case of haptenated
`oligonucleotides. The phenomenon is largely restricted to injections of 1 ,umol and
`larger. This phenomenon is not a problem if the column is used for only one oligonu(cid:173)
`cleotide. If the intended use for the column is for multiple oligonucleotide separa(cid:173)
`tions, the probability of contamination is unacceptably high. From the above experi(cid:173)
`ences, the criteria for a suitable HPLC support were determined to be high loading
`capacity, good resolution, stability to extremes of pH and salt concentration and no
`ghosting. As the PRP-1 column fulfilled all of the criteria save the last one, it seemed a
`
`5
`
`

`

`90
`
`R. L. MORGAN, J. E. CELEBUSKI
`
`peak 1 -
`
`-
`
`peak 2
`
`16.19
`
`16.40
`
`Absorbance
`A29onm
`
`0
`
`5
`
`10
`
`15
`
`20
`
`25
`
`Time
`(minutes)
`
`Fig. 2. Injection of 200 flg of a 25-mer, 5'-end labeled with FITC. Column is Hamilton PRP-1. Peak I,
`eluting at 16.19 min, is unreacted starting material, while peak 2, eluting at 16.4 min, is haptenated
`oligonucleotide.
`
`worthwhile exercise to examine other polystyrene-based supports which were cova(cid:173)
`lently modified. The EM Science Polyspher RP-18 column (15 x 0.46 em) is a 3-C 18
`styrene/3-C 18-1,4-divinylbenzene cross-linked polymeric support which is generally
`used in situations requiring ODS column resolution under unusual salt or pH condi(cid:173)
`tions. We have found that this support is admirably suited to the task of resolving
`haptenated from non-haptenated oligonucleotide, as well as removal of excess hapte(cid:173)
`nation reagent. The separation time between starting material and product ranges
`between 9 and II min, with a flow-rate of0.6 mljmin on the analytical column. Fig. 3
`shows the resolution seen for a typical preparation of a fluoresceinated, end-labeled
`oligonucleotide, while Fig. 4 depicts the separation between terminally biotinylated
`oligonucleotide from terminally aminated starting oligonucleotide. We have obtained
`1.5 mg of purified 25-mer from the analytical EM column in a single crude injection of
`2.2 mg, with recovery of unreacted starting material. Importantly, no ghosting is
`observed when blanks are injected onto an RP-18 column after a sample run. Best
`separation results are obtained on the RP-18 when the pH of the load matches of the
`pH of the eluent.
`
`6
`
`

`

`HPLC PURIFICATION OF HAPTENATED OLIGONUCLEOTIDES
`
`91
`
`1.5
`
`s
`
`1.0
`
`Absorbance
`A290 nm
`
`0.5
`
`0
`
`10
`
`20
`
`30
`
`Time
`(minutes)
`
`Fig. 3. HPLC trace of 249 J.tg loading of a 24-mer, 5'-end labeled with FITC. Column is EM Science
`Polyspher RP-18. Peaks 3 and4, eluting at 9.9 and 12.3 min, are starting oligonucleotide. Peak 5, eluting at
`21.3 min, is FITC-labeled material.
`
`Finally, hybridization of the haptenated oligonucleotides to their complemen(cid:173)
`tary sequences has been examined qualitatively by hyperchromicity measurements
`and quantitatively by size-exclusion chromatography on a high-performance liquid
`chromatograph (Fig. 5). In all cases, the terminally haptenated oligonucleotides were
`able to hybridize to their complementary strands.
`
`CONCLUSION
`
`We have found that C 18 column HPLC will not adequately separate fluorescei(cid:173)
`nated from non-fluoresceinated oligonucleotide, as checked by polyacrylamide gel
`electrophoresis. PAGE itself has the problem of low loading capacity. Unmodified
`polystyrene reversed-phase columns have high loading capacity and afford some sep(cid:173)
`aration of haptenated from non-haptenated oligonucleotide, but have "ghosting" as
`a setback. Taking all of these limitations into account, we now employ the RP-18
`HPLC column from EM Science to separate haptenated from non-haptenated oligo(cid:173)
`nucleotide. It has the characteristics of high loading capacity, good resolution, and no
`"ghosting" in its favor.
`
`7
`
`

`

`92
`
`R. L. MORGAN, J. E. CELEBUSKI
`
`1.5
`
`Absorbance
`A290DD1
`
`1. 0
`
`0.5
`
`Time
`(minutes)
`
`25
`
`Fig. 4, Injection of 345 pg of a 25-mer, 3' -end labeled with biotin-(aminocaproyi)2-N-hydroxysnccinimide
`ester. Column is EM Science Polyspher RP-18. Peaks 3 and 4, eluting at 10.4 and 13 min, are starting
`oligonucleotide, while peak 5, eluting at 21 min, is biotinylated material.
`
`A
`
`B
`
`7.07
`
`7.77
`
`Absorbance
`A260 nm
`
`0
`
`5
`
`10
`
`0
`
`5
`
`10
`
`Time
`(minutes)
`
`Fig. 5. (A) Injection of 24-mer, 5' -end labeled with FITC and hybridized to complementary strand, 7.07
`min peak; (B) 24-mer by itself, 7. 77 min retention time. Note the residual peak at 7. 74 min from unhybrid(cid:173)
`ized material in (A). This disappears upon further admixture with complementary DNA. Column is Bio-Sil
`SEC-125.
`
`8
`
`

`

`HPLC PURIFICATION OF HAPTENATED OLIGONUCLEOTIDES
`
`93
`
`ACKNOWLEDGEMENTS
`
`We thank Cliff Chan for the oligonucleotide synthesis work and Julie Johanson
`for some of the purifications. We thank Abbott Laboratories for allowing the publi(cid:173)
`cation of this manuscript. Finally, we thank a reviewer for calling ref. 7 to our atten(cid:173)
`tion.
`
`REFERENCES
`
`I A.M. Maxam and W. Gilbert, Proc. Nat!. Acad. Sci. U.S.A., 74 (1977) 560--564.
`2 G. H. Keller, C. U. Cumming, C.-P. Huang, M. M. Manak and R. Ting, Anal. Biochem., 170 (1988)
`441-450.
`3 G. H. Keller, D.-P. Huang and M. M. Manak, Anal. Biochem., 177 (1989) 392-395.
`4 P. S. Nelson, R. Sherman-Gold and R. Leon, Nucleic Acids Res., 17 (1989) 7179-7186.
`5 G. B. Dreyer and P. B. Dervan, Proc. Nat/. Acad. Sci. U.S.A., 82 (1985) 968-972.
`6 G. Tous, J. Fausnaugh, P. Vieira and S. Stein, J. Chromatogr., 444 (1988) 67-77.
`7 L. M. Smith, S. Fung, M. W. Hunkapiller, T. J. Hunkapiller and L. E. Hood Nucleic Acids Res., 13
`(1985) 2399-2412.
`8 J. Telser, K. A. Cruickshank, L. E. Morrison and T. L. Netzel, J. Am. Chern. Soc., 111 (1989) 6966-
`6976.
`9 A. C. Forster, J. L. Mcinnis, D. C. Skingle and R. H. Symons, Nucleic Acids Res., 13 (1985) 745-761.
`10 R. P. Viscidi, C. J. Connelly and R. H. Yolken, J. Clin. Microbial., 23 (1986) 311-317.
`II A.Reisfeld, J. M. Rothenberg, E. A. Bayer and M. Wilchek, Biochem. Biophys. Res. Commun., 142
`(1987) 519-526.
`12 M. W. Germann, R. T. Pon and J. H. van de Sande, Anal. Biochem., 165 (1987) 399-405.
`13 S. Ikuta, R. Chattopadhyaya and R. E. Dickerson, Anal. Chern., 56 (1984) 2253-2257.
`14 User Bulletin. No. 50, Applied Biosystems, Foster City, CA, 1988.
`
`9
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket